Who are Topical analgesic's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Topical capsaicin, Capsaicine low dose 0.04 %, Relief Pro cream, Pain Relief Ointment, Qutenza Patch, Capsaicin 8%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/topical-analgesic.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Topical analgesic — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Topical analgesic (Topical analgesic) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical analgesic. Area: Pain Management.

marketed Topical analgesic Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Topical analgesic (Topical analgesic) — Grünenthal GmbH. Topical analgesics work by delivering pain-relieving agents directly to the skin and underlying tissues to reduce localized pain sensation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Topical analgesic TARGET	Topical analgesic	Grünenthal GmbH	marketed	Topical analgesic
Topical capsaicin	Topical capsaicin	The University of Texas Health Science Center, Houston	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)
Capsaicine low dose 0.04 %	Capsaicine low dose 0.04 %	University Hospital, Clermont-Ferrand	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)
Relief Pro cream	Relief Pro cream	Bayer	marketed	Topical analgesic
Pain Relief Ointment	Pain Relief Ointment	Johnson & Johnson Consumer and Personal Products Worldwide	marketed	Topical analgesic
Qutenza Patch	Qutenza Patch	M.D. Anderson Cancer Center	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)
Capsaicin 8%	Capsaicin 8%	Averitas Pharma, Inc.	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical analgesic class)

Bayer · 1 drug in this class
EpiCept Corporation · 1 drug in this class
Express Specialty Pharmacy · 1 drug in this class
Georg Kägi, MD · 1 drug in this class
Grünenthal GmbH · 1 drug in this class
Henry Ford Health System · 1 drug in this class
Johnson & Johnson Consumer and Personal Products Worldwide · 1 drug in this class
NeurogesX · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Topical analgesic — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-analgesic. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing